Drugs that contain Divalproex Sodium
1. Depakote Er patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6713086 | ABBVIE | Controlled release formulation of divalproex sodium |
Dec, 2018
(5 years ago) | |
| US6528091 | ABBVIE | Controlled release formulation of divalproex sodium |
Dec, 2018
(5 years ago) | |
| US6720004 | ABBVIE | Controlled release formulation of divalproex sodium |
Dec, 2018
(5 years ago) | |
| US6511678 | ABBVIE | Controlled release formulation of divalproex sodium |
Dec, 2018
(5 years ago) | |
| US6528090 | ABBVIE | Controlled release formulation of divalproex sodium |
Dec, 2018
(5 years ago) | |
| US6419953 | ABBVIE | Controlled release formulation of divalproex sodium |
Dec, 2018
(5 years ago) | |
|
US6528090 (Pediatric) | ABBVIE | Controlled release formulation of divalproex sodium |
Jun, 2019
(4 years ago) | |
|
US6511678 (Pediatric) | ABBVIE | Controlled release formulation of divalproex sodium |
Jun, 2019
(4 years ago) | |
|
US6419953 (Pediatric) | ABBVIE | Controlled release formulation of divalproex sodium |
Jun, 2019
(4 years ago) | |
|
US6720004 (Pediatric) | ABBVIE | Controlled release formulation of divalproex sodium |
Jun, 2019
(4 years ago) | |
|
US6713086 (Pediatric) | ABBVIE | Controlled release formulation of divalproex sodium |
Jun, 2019
(4 years ago) | |
|
US6528091 (Pediatric) | ABBVIE | Controlled release formulation of divalproex sodium |
Jun, 2019
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Pediatric Exclusivity(PED) | Sep 24, 2011 |
Market Authorisation Date: 31 May, 2002
Treatment: Treatment of epilepsy and/or migraine.; Treatment of epilepsy
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of DEPAKOTE ER before it's drug patent expiration?
More Information on Dosage
DEPAKOTE ER family patents
